Four regulatory news updates in ophthalmology

From late October through November, notable regulatory decisions were made by the U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services and the Irish Health Products Regulatory Authority – from recommendations to approve a multifocal toric IOL to positive reimbursement statuses for implants and injections.Ocular Surgery News spotlights four regulatory decisions made that ophthalmologists should know to better treat patients who require such procedures.